Ganga Pharmaceuticals Ltd.
12.50+0.0 (+0.00%)
8 Sep, 12:00 AM
Income Statement
Abridged
Understanding Income Statement
Ganga Pharmaceuticals Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Ganga Pharmaceuticals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Ganga Pharmaceuticals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
We don't have enough data to show Annual Consolidated Cash Flow data for Ganga Pharmaceuticals Ltd.
Business Segment Analysis
Ganga Pharmaceuticals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
We don't have enough data to show business segment analysis for Ganga Pharmaceuticals Ltd.
Regional Segment Analysis
Ganga Pharmaceuticals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
We don't have enough data to show regional segment analysis for Ganga Pharmaceuticals Ltd.
Historical Segment Analysis
Track how Ganga Pharmaceuticals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
We don't have enough data to show segments for Ganga Pharmaceuticals Ltd.
Frequently Asked Questions
What is the revenue of Ganga Pharmaceuticals Ltd.?
The latest trailing twelve month revenue of Ganga Pharmaceuticals Ltd. is ₹ 2.83 Cr, reflecting a 1-year growth of 7.22% and a 3-year CAGR of 3.02%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Ganga Pharmaceuticals Ltd.?
The latest trailing twelve month net profit (PAT) of Ganga Pharmaceuticals Ltd. is ₹ 0.10 Cr, with a 3-year earnings CAGR of 20.65%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Ganga Pharmaceuticals Ltd.?
The trailing twelve month EBITDA of Ganga Pharmaceuticals Ltd. is approximately ₹ -0.02 Cr (based on an operating margin of -0.59%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Ganga Pharmaceuticals Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Ganga Pharmaceuticals Ltd. is 0.17. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Ganga Pharmaceuticals Ltd.?
The debt-to-equity ratio of Ganga Pharmaceuticals Ltd. stands at 0.13. The interest coverage ratio is -0.13x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Ganga Pharmaceuticals Ltd.?
The estimated book value per share of Ganga Pharmaceuticals Ltd. is 14.06 (derived from a P/B ratio of 0.89 and market price of ₹ 12.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Ganga Pharmaceuticals Ltd.?
The trailing twelve month operating cash flow of Ganga Pharmaceuticals Ltd. is ₹ -0.96 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Ganga Pharmaceuticals Ltd. report consolidated or standalone financials?
Ganga Pharmaceuticals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.